Home > Insider Trading > Filing (0001384101-20-000060)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1384101	Veracyte Inc.	VCYT	Services-Medical Laboratories (8071)	205455398

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1588970	H Bonnie Anderson	6000 Shoreline Court Suite 300 South San Francisco CA 94080	Chairman And Ceo	Yes	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2020-05-11	1,870	$0.00	274,183	No	4	A	Direct
Common Stock	Acquisiton	2020-05-11	20,000	$4.00	294,183	No	4	M	Direct
Common Stock	Disposition	2020-05-11	19,800	$26.66	274,383	No	4	S	Direct
Common Stock	Disposition	2020-05-11	200	$27.10	274,183	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	A	Direct
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (right to buy)	Acquisiton	2020-05-11	10,920	$0.00	10,920	$26.55
Common Stock	Stock Option (right to buy)	Disposition	2020-05-11	20,000	$4.00	20,000	$4.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
10,920		2030-05-10	No	4	A	Direct
46,853		2023-02-04	No	4	M	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	99,085	Indirect	The Bonnie H. Anderson Living Trust

Footnotes

Restricted stock units awarded on May 11, 2020 vest 24 months from May 1, 2020 subject to continuing employment of the Reporting Person on the vesting date.
The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 2, 2019.
Represents weighted average sales price. Sale prices for the transactions range from $26.08 to $27.03. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.
The stock options awarded on May 11, 2020 vest 24 months from May 1, 2020 subject to continuing employment of the Reporting Person on the vesting date.
On February 5, 2013, the Reporting Person was issued 3 stock options which have different vesting dates, all of which are vested. These options include: (1) 112,500, of which 5,241 shares are exercised on 5/11/2020 and 25,000 options remain, (2) 12,500, of which 12,500 are exercised on 5/11/2020 and none remain and (3) 24,112, of which 2,259 were exercised on 5/11/2020 and 21,853 remain.
The options are fully vested.